These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29629673)

  • 1. Pan drug-resistant Serratia marcescens: An emerging threat.
    Moodley K; Peer AKC; Govind CN
    S Afr Med J; 2018 Mar; 108(4):12264. PubMed ID: 29629673
    [No Abstract]   [Full Text] [Related]  

  • 2. Serratia marcescens producing SME carbapenemases: an emerging resistance problem in the UK?
    Hopkins KL; Findlay J; Meunier D; Cummins M; Curtis S; Kustos I; Mustafa N; Perry C; Pike R; Woodford N
    J Antimicrob Chemother; 2017 May; 72(5):1535-1537. PubMed ID: 28108680
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome evolution and plasticity of Serratia marcescens, an important multidrug-resistant nosocomial pathogen.
    Iguchi A; Nagaya Y; Pradel E; Ooka T; Ogura Y; Katsura K; Kurokawa K; Oshima K; Hattori M; Parkhill J; Sebaihia M; Coulthurst SJ; Gotoh N; Thomson NR; Ewbank JJ; Hayashi T
    Genome Biol Evol; 2014 Aug; 6(8):2096-110. PubMed ID: 25070509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful management with fosfomycin + ceftazidime of an infection caused by multiple highly-related subtypes of multidrug-resistant and extensively drug-resistant KPC-producing Serratia marcescens.
    Rodríguez C; Brengi S; Cáceres MA; Mochi S; Viñas MR; Rizza CA; Merletti G; Bru E; Assa JD; Raya RR; Centrón D
    Int J Antimicrob Agents; 2018 Nov; 52(5):737-739. PubMed ID: 30092272
    [No Abstract]   [Full Text] [Related]  

  • 6. Serratia marcescens prosthesis infection successfully treated with meropenem after imipenem failure.
    Lefort A; Righi S; Jauréguy F; Bégué T; Robineau M; Bouchaud O; Lortholary O
    J Infect; 2005 Aug; 51(2):E45-7. PubMed ID: 16038749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of Serratia marcescens in a hospital.
    Sekiguchi J; Fujino T; Kuroda E; Konosaki H; Nishimura H; Saruta K; Kawana A; Yamanishi F; Kudo K; Kondo T; Yazaki Y; Kuratsuji T; Kirikae T
    Jpn J Infect Dis; 2004 Apr; 57(2):78-80. PubMed ID: 15118217
    [No Abstract]   [Full Text] [Related]  

  • 8. Case report of a successfully treated gentamicin and ciprofloxacin resistant Serratia marcescens prosthetic joint infection.
    Cannon TA; Partridge DG; Boden RA; Townsend R; Stockley I
    Ann R Coll Surg Engl; 2014 Nov; 96(8):e23-5. PubMed ID: 25350172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serratia marcescens.
    Hejazi A; Falkiner FR
    J Med Microbiol; 1997 Nov; 46(11):903-12. PubMed ID: 9368530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serratia marcescens infections. Bacteriological study, antibiogram, and clinical significance].
    Paredes L; Fernández M; Paredes M; Fuenzalida P; Paredes L
    Rev Med Chil; 1974 Feb; 102(2):109-17. PubMed ID: 4157414
    [No Abstract]   [Full Text] [Related]  

  • 12. CTX-M and TEM as predominant types of extended spectrum beta-lactamases among Serratia marcescens isolated from solid organ recipients.
    Mlynarczyk A; Szymanek K; Sawicka-Grzelak A; Pazik J; Buczkowska T; Durlik M; Lagiewska B; Pacholczyk M; Chmura A; Paczek L; Mlynarczyk G
    Transplant Proc; 2009 Oct; 41(8):3253-5. PubMed ID: 19857723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serratia marcescens: an emerging microorganism in the neonatal intensive care unit.
    Aygün C; Yiğit S; Gür D; Erdem G; Oran O; Tekinalp G; Yurdakök M
    Turk J Pediatr; 2000; 42(3):219-22. PubMed ID: 11105621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C
    Epidemiol Infect; 1994 Feb; 112(1):125-31. PubMed ID: 8119351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of antidiabetics as Serratia marcescens virulence inhibitors.
    Hegazy WAH; Khayat MT; Ibrahim TS; Youns M; Mosbah R; Soliman WE
    Braz J Microbiol; 2021 Jun; 52(2):627-638. PubMed ID: 33686563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serratia marcescens harboring SME-4 in Brazil: A silent threat.
    Cayô R; Leme RC; Streling AP; Matos AP; Nodari CS; Chaves JR; Brandão JL; de Almeida MF; Carrareto V; de Castro Pereira MA; de Almeida JP; Ferreira DC; Gales AC
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):357-358. PubMed ID: 28159445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of quorum sensing regulated biofilm formation in Serratia marcescens causing nosocomial infections.
    Bakkiyaraj D; Sivasankar C; Pandian SK
    Bioorg Med Chem Lett; 2012 May; 22(9):3089-94. PubMed ID: 22487181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western Germany.
    Wendel AF; Kaase M; Autenrieth IB; Peter S; Oberhettinger P; Rieber H; Pfeffer K; MacKenzie CR; Willmann M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a fluoroquinolone-resistant Serratia marcescens clinical isolate without quinolone resistance-determining region mutations.
    Yang H; Chen G; Cheng J; Liu Y; Hu L; Ye Y; Li J
    Ann Lab Med; 2014 Nov; 34(6):487-8. PubMed ID: 25368830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.